Hypertension

High blood pressure increases a patient's risk of heart attack, stroke and other diseases. Most people with hypertension have no symptoms. The Centers for Disease Control and Prevention (CDC) says nearly half of U.S. adults have hypertension, or high blood pressure, and only about 1 in 4 of those individuals has their hypertension under control. The World Health Organization (WHO) expects the epidemic of hypertension world-wide will exceed 1.56 billion people by 2025. Major efforts are underway to better control this primary risk factor through screenings, medication and invasive procedures such as renal denervation in severely uncontrolled patients.

Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors
Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.
FDA clears new AI model for pulmonary hypertension
The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.
Morning exercise may have added benefits for the heart
With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.
Ultrasound RDN system launches in Japan—cardiologist calls it a ‘significant step forward’
Recor Medical's Paradise Ultrasound RDN technology is now available in Japan, home to an estimated 43 million adults with hypertension.
Medtronic’s RDN system receives new reimbursement approval
More than 40 million adults now have improved access to Medtronic's Symplicity Spyral renal denervation technology.

Whoop, a Boston-based wearable technologies company, has raised $575 million in new financing at a $10.1 billion valuation. Investors include Abbott, Mayo Clinic, LeBron James and Cristiano Ronaldo.

Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors

Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.

AI model algorithm tablet digital patient data

FDA clears new AI model for pulmonary hypertension

The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.

Morning exercise may have added benefits for the heart

With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.

Paradise Ultrasound image courtesy of Recor Medical.

Ultrasound RDN system launches in Japan—cardiologist calls it a ‘significant step forward’

Recor Medical's Paradise Ultrasound RDN technology is now available in Japan, home to an estimated 43 million adults with hypertension.

The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.

Medtronic’s RDN system receives new reimbursement approval

More than 40 million adults now have improved access to Medtronic's Symplicity Spyral renal denervation technology.

Michael Honigberg, MD, MPP, a preventive cardiologist and cardiovascular researcher at Massachusetts General Hospital, explains how preeclampsia and gestational hypertension during pregnancy can elevate cardiovascular risks later in life and how to best manage these patients.

How hypertension during pregnancy impacts a woman's long-term cardiovascular health

Emerging research suggests that the early postpartum period may represent a critical window for influencing a woman's long-term cardiovascular health.

Tap water in US linked to potential cardiovascular risks

“This is not about alarming people,” one researcher said. “It’s about recognizing an environmental factor that may be contributing to high blood pressure in some communities and making sure it’s part of the public health conversation."

Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM, medical director, heart and vascular service line and the Benson Ford Chair in Cardiology at Henry Ford Health, member of board, Society for Cardiovascular Angiography and Interventions (SCAI), the explains how hospitals can set up renal denervation (RDN) programs and how the reimbursement landscape is changing with new Medicare coverage.

How to get reimbursed for renal denervation

Herbert D. Aronow, MD, reviewed the many ways the reimbursement landscape is changing thanks to new Medicare policies. “This is a really exciting time in the renal denervation space," he said.